Evidence of GATA-3-dependent Th2 commitment during the in vivo immune response

International Immunology

Volumn 16, Issue 1, 2004, Pages 179-187

  Tamauchi, Hidekazu ^a   Terashima, Masazumi ^b   Ito, Mamoru ^c   Maruyama, Hiroko ^d   Ikewaki, Nobunao ^e   Inoue, Matsuhisa ^a   Gao, Xiuhua ^f,g   Hozumi, Katsuto ^f   Habu, Sonoko ^f  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^c CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^d KITASATO UNIVERSITY   (Japan)

^e KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^f TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g CUMC Cancer Center   (United States)

Author keywords

Antigen specific Ig isotype; GATA 3; GATA 3 transgenic mice; Ovalbumin specific TCR transgenic mice; Th2 cytokine

Indexed keywords

CD4 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 5; OVALBUMIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR GATA 3;

AEROSOL; ANIMAL CELL; ANIMAL CELL CULTURE; ANTIBODY BLOOD LEVEL; ANTIGEN SPECIFICITY; ARTICLE; CELL POLARITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOREACTIVITY; IMMUNOSTIMULATION; IN VIVO STUDY; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH2 CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD4; BRONCHOALVEOLAR LAVAGE FLUID; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GATA3 TRANSCRIPTION FACTOR; IMMUNOBLOTTING; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-13; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH2 CELLS; TRANS-ACTIVATORS;

EID: 0347359048     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh026     Document Type: Article

References (46)

1. Abbas, A. K., Murphy, K. M. and Sher, A. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
2. + T cell responses: the alternative approaches. Annu. Rev. Immunol. 15:297.
3. h2 paradigm. Immunol. Today 18:263.
4. Lichtman, A. H. and Abbas, A. K. 1997. T-cell subsets: recruiting the right kind of help. Curr. Biol. 7:242.
5. O'Garra, A. 1998. Cytokines induces the development of functionally heterogeneous T helper cell subsets. Immunity 8:275.
6. h cells. J. Exp. Med. 177:1199.
7. h2-like helper effector. J. Immunol. 145:3796.
8. + T cells enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc. Natl Acad. Sci. USA 90:10188.
9. h2 cell development. J. Exp. Med. 168:4538.
10. h1 differentiation by both interleukin 4-dependent and -independent mechanisms. J. Exp. Med. 188:1859.
11. h2 development and commitment. Immunity 12:27.
12. Pandolfi, P. P., Roth, M. E., Karis, A., Leonard, M. W., Dzierzak, E., Grosvels, F. G., Engel, J. D. and Lindenbaum, M. H. 1995. Targeted disruption of the GATA-3 gene cause severe abnormalities in the nervous system and in fetal live hematopoiesis. Nat. Genet. 11:40.
13. Nawijn, M. C., Ferreira, R., Dingjan, G. M., Kahre, O., Drabek, D., Karis, A., Grosveld, F. and Hendriks, R. W. 2001. Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice. J. Immunol. 167:715.
14. h2 cytokine gene expression in CD4 T cells. Cell 89:587.
15. h2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272:21597.
16. h2) development mediated by GATA-3. J. Exp. Med. 193:643.
17. Zhang, D. H., Yang, L. and Ray, A. 1998. Differential responsiveness of the IL-5 and IL-4 gene to transcription factor GATA-3. J. Immunol. 161:3817.
18. h1 cells in addition to inducing IL-4 and IL-5 levels. Clin. Immunol. 91:134.
19. h2-specific expression of the IL-5 gene: a role for a GATA-binding protein. J. Immunol. 160:2343.
20. h1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 9:745.
21. Zhang, D. H., Yang, L., Cohn, L, Parkyn, L., Homer, R., Ray, P. and Ray, A. 1999. Inhibition of allergic inflammation in murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 11:473.
22. h2-committed T cell compartment in vivo. J. Immunol. 167:724.
23. Sato, T., Sasahara, T., Nakamura, Y., Osaki, T., Hasegawa, T., Tadakuma, T., Arata, Y., Kumagai, Y., Katsuki, M. and Habu, S. 1994. Naive T cells can mediate delayed-type hypersensitivity response in T cell receptor transgenic mice. Eur. J. Immunol. 24:1512.
24. Andrews, N. C. and Faller, D. V. 1991. A rapid micropreparation technique for extraction of DNA-binding protein from limiting number of mammalian cells. Nucleic Acids Res. 19:249.
25. Strath, M., Warren, D. J. and Sanderson, C. J. 1985. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J. Immunol. Methods 83:209.
26. Campbell, H. D., Tucker, W. Q., Hort, Y., Martinson, M. E., Mayo, G., Clutterbuck, E. J., Sanderson, C. J. and Young, I. G. 1987. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor interleukin5. Proc. Natl Acad. Sci. USA 84:6629.
27. Yamaguchi, Y., Hayashi, Y., Sugama, Y., Miura, Y., Kasahara, T., Kitamura, S., Torisu, M., Mita, S., Tominaga, A. and Takatsu, K. 1988. Highly purified murine interleukin-5, IL-5, stimulates eosinophil function and prolongs in vitro survival. J. Exp. Med. 167:1737
28. Campbell, H. D., Tucker, W. Q., Hort, Y., Martinson, M. E., Mayo, G., Clutterbuck, E. J., Sanderson, C. J. and Young, I. G. 1987. Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor interleukin5. Proc. Natl Acad. Sci. USA 84:6629.
29. Purkerson, J. M. and Isakson, P. C. 1992. Interleukin 5 (IL-5) provides a signal that is required in addition to IL-4 for isotype switching to immunoglobulin (Ig) G1 and IgE. J. Exp. Med. 175:973.
30. Emonson, C. L., Bell, S. E., Jones, A., Wisden, W. and Mckenzie, A. N. J. 1996. Interleukin (IL)-4 independent induction of immunoglobulin (Ig) E, and perturbation of T cell development in transgenic mice expressing IL-13. J. Exp. Med. 188:399.
31. Morawetz, R. A., Gabriele, L., Rizzo, L. V., Noben-trauth, N., Kuhn, R., Rajewsky, K., Muller, W., Doherty, T. M., Finkelman, F., Coffman, R. L. and Morse, H. C., III 1996. Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig) E in the mouse. J. Exp. Med. 184:1651.
32. Mizoguchi, D., Uehara, S., Akira, S., Takatsu, K. 1999. IL-5 induces IgG1 isotype switch recombination in mouse CD38-activated sIgD-positive B lymphocytes. J. Immunol. 162:2812.
33. Coffman, R. L., Lebman, D. A. and Shrader, B. 1989. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J. Exp. Med. 170:1039.
34. Sonoda, E., Matsumoto, R., Hitoshi, Y., Ishii, T., Sugimoto, M., Araki, S., Tominaga, A., Yamaguchi, N. and Takatsu, K. 1989. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 170:1415
35. Ramsay, A. J. and Kohinen, C. M. 1993. Interkeukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo. Eur. J. Immunol. 23:3141.
36. Ranganath, S., Ouyang, W., Bhattarcharya, D., Sha, W. C., Grupe, A., Peltz, G. and Murphy, K. M. 1998. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161:3822.
37. Yamashita, M., Ukai-Tadenuma, M., Kimura, M., Omori, M., Inami, M., Taniguchi, M. and Nakayama, T. 2002. Identification of a conserved GATA-3 response element upstream proximal from the interleukin-13 gene locus. J. Biol. Chem. 277:42399.
38. Coffman, R. L., Lebman, D. A. and Rothman, P. 1993. Mechanism and regulation of immunoglobulin isotype swithing. Adv. Immunol. 54:229.
39. Lai, Y. H. and Mosmann, T. R. 1999. Mouse IL-13 enhances antibody production in vivo and acts directly on B cells in vitro to increase survival and hence antibody production. J. Immunol. 162:78.
40. Ramsay, A. J., Husband, A. J., Ramshaw, I. A., Bao, S., Matthaei, K. I., Koehler, G. and Kopf, M. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264:561.
41. Tominaga, A., Takaki, S., Koyama, N., Katoh, S., Matsumoto, R., Migita, M., Hitoshi, Y., Hosoya, Y., Yamauchi, S., Kanai, Y., Miyazaki, J., Usaku, G., Yamamura, K. and Takatsu, K. 1991. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production. J. Exp. Med. 173:429.
42. Brandtzaeg, P., Farstad, I. N., Johansen, F. E., Morton, H. C., Norderhaug, I. N. and Yamanaka, T. 1999. The B-cell system of human mucosae and exocrine glands. Immunol. Rev. 171:45.
43. Kelly, E. A., Cruz, E. S., Hauda, K. M. and Wassom, D. L. 1991. IFN-gamma- and IL-5-producing cells compartmentalize to different lymphoid organs in Trichinella spiralis-infected mice. J. Immunol. 147:306.
44. Mega, J., McGhee, J. R. and Kiyono, H. 1992. Cytokine- and Ig-producing T cells in mucosal effector tissues: analysis of IL-5- and IFN-gamma-producing T cells, T cell receptor expression, and IgA plasma cells from mouse salivary gland-associated tissues J. Immunol. 148:2030.
45. Foster, P. S., Hogan, S. P., Ramsay, A. J., Matthaei, K. I. and Young, I. G. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195.
46. Coffman, R. L., Seymour, B. W., Hudak, S., Jackson, J. and Rennick, D. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245:308.